It is hoped that these results can contribute to the advancement of the current understanding of the dynamics of NF-κB action in the progression of CLL to RS and help to identify the main pathways for intervention in this disease progression. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.